Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 May 19;10(1):88-94.
doi: 10.1159/000444442. eCollection 2016 Jan-Apr.

Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab

Affiliations
Case Reports

Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab

Glenn Harvin et al. Case Rep Gastroenterol. .

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abscesses, nodules, and fistulas predominantly in the groin and axillae. The association between HS and Crohn's disease (CD) has been well documented. Tumor necrosis factor (TNF) inhibitors have shown to be effective in treating both HS and CD. We report 2 patients who developed HS while on TNF inhibitor treatment for CD.

Keywords: Adalimumab; Crohn's disease; Hidradenitis Suppurativa.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
HS of the posterior thigh.
Fig. 2
Fig. 2
HS of the left groin.
Fig. 3
Fig. 3
Psoriasiform rash that developed on her back.
Fig. 4
Fig. 4
Psoriasiform skin lesion at the adalimumab injection site.

Similar articles

Cited by

References

    1. Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin. 2010;28:779–793. - PubMed
    1. Kamal N, Cohen BL, Buche S, Delaporte E, Colombel JF. Features of patients with Crohn's disease and hidradenitis suppurativa. Clin Gastroenterol Hepatol. 2016;14:71–79. - PubMed
    1. Yadav S, Singh S, Edakkanambeth Varayil J, et al. Hidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2016;14:65–70. - PMC - PubMed
    1. Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157:846–855. - PubMed
    1. Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323–333. quiz 591. - PubMed

Publication types

LinkOut - more resources